A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases

Principles of Biomedical Ethics

(2012) · Thieves of Virtue · doi:10.7551/mitpress/9079.003.0009 · Cited by 13,453 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works

Finding the missing heritability of complex diseases

Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336 · see citing works

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008

Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.011 · Cited by 5,128 · see citing works

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · see citing works

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619 · see citing works

Classificação Internacional de Funcionalidade (CIF)

Battistella, L. R., & de Brito, C. M. M. (2002) · Acta Fisiátrica · doi:10.5935/0104-7795.20020003 · Cited by 4,470 · see citing works

Untitled work

(1994) · Medical Entomology and Zoology · Cited by 4,156 · see citing works

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · see citing works

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · see citing works

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works

The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years

Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007) · Medical Care · doi:10.1097/01.mlr.0000258615.42478.55 · Cited by 3,118 · see citing works

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891 · see citing works

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · see citing works

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544 · see citing works

Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J. M., Kasarskis, E. J., Munsat, T. L., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,526 · see citing works

Understanding Disability: From Theory to Practice

OLIVER, M. J. (1995) · Cited by 2,381 · see citing works

A polymorphic DNA marker genetically linked to Huntington's disease

Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340 · see citing works

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234 · see citing works

The Quality of American Life: Perceptions, Evaluations, and Satisfactions.

Boguslaw, R., Campbell, A., Converse, P. E., & Rodgers, W. L. (1977) · Social Forces · doi:10.2307/2577440 · Cited by 1,947 · see citing works

Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1

Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632 · see citing works

Cognition and anatomy in three variants of primary progressive aphasia

Gorno‐Tempini, M. L., Dronkers, N. F., Rankin, K. P., Ogar, J. M., Phengrasamy, L., Rosen, H. J., Johnson, J. K., Weiner, M. W., & Miller, B. L. (2004) · Annals of Neurology · doi:10.1002/ana.10825 · Cited by 1,608 · see citing works

The International Classification of Functioning, Disability and Health (ICF)

Bickenbach, J. E., & Jerosch‐Herold, C. (2009) · UEA Digital Repository (University of East Anglia) · Cited by 1,600 · see citing works

Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease

Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219 · see citing works

Untitled work

(1995) · Cited by 1,191 · see citing works

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110 · see citing works

The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study

Chaudhuri, К. R., Martínez‐Martín, P., Brown, R. G., Sethi, K. D., Stocchi, F., Odin, P., Ondo, W. G., Abe, K., Macphee, G. J. A., MacMahon, D., et al. (2007) · Movement Disorders · doi:10.1002/mds.21596 · Cited by 1,092 · see citing works

Whatever does not kill us: cumulative lifetime adversity, vulnerability, and resilience

Seery, M. D., Holman, E. A., & Silver, R. C. (2010) · Journal of Personality and Social Psychology · doi:10.1037/a0021344 · Cited by 954 · see citing works

PRINCIPLES OF BIOMEDICAL ETHICS

Iserson, K. V. (1999) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70060-2 · Cited by 949 · see citing works

Sample size and item calibration stability

Linacre, J. M. (1994) · Medical Entomology and Zoology · Cited by 888 · see citing works

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length

Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & on behalf of an International Huntington's Disease Collaborative Group (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00241.x · Cited by 820 · see citing works

Detection of Huntington's disease decades before diagnosis: the Predict-HD study

Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., NANCE, M. A., Guttman, M., Johnson, S., MacDonald, M. E., Beglinger, L. J., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.128728 · Cited by 808 · see citing works

Neuro-QOL

Cella, D. F., Lai, J., Nowinski, C. J., Victorson, D. E., Peterman, A. H., Miller, D. M., Béthoux, F., Heinemann, A. W., Rubin, S., Cavazos, J. E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318258f744 · Cited by 789 · see citing works

Multivariate Analysis: The Need for Data, and other Problems

Everitt, B. J. (1975) · The British Journal of Psychiatry · doi:10.1192/bjp.126.3.237 · Cited by 779 · see citing works

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747 · see citing works

The overlap of amyotrophic lateral sclerosis and frontotemporal dementia

Lomen, C. E., Anderson, T. T., & Miller, B. L. (2002) · Neurology · doi:10.1212/wnl.59.7.1077 · Cited by 699 · see citing works

The genetic epidemiology of neurodegenerative disease

Bertram, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24761 · Cited by 680 · see citing works

CAG repeat number governs the development rate of pathology in Huntington's disease

Penney, J. B., Vonsattel, J., MacDonald, M. E., Gusella, J. F., & Myers, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410521 · Cited by 670 · see citing works

TDP‐43 A315T mutation in familial motor neuron disease

Gitcho, M. A., Baloh, R. H., Chakraverty, S., Mayo, K., Norton, J. B., Levitch, D., Hatanpaa, K. J., White, C. L., Bigio, E. H., Caselli, R. J., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21344 · Cited by 619 · see citing works

Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease

Postuma, R. B., Aarsland, D., Barone, P., Burn, D. J., Hawkes, C. H., Oertel, W. H., & Ziemssen, T. (2012) · Movement Disorders · doi:10.1002/mds.24996 · Cited by 615 · see citing works

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

Tabrizi, S. J., Scahill, R. I., Dürr, A., Roos, R. A. C., Leavitt, B. R., Jones, R., Landwehrmeyer, G. B., Fox, N. C., Johnson, H. J., Hicks, S. L., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70276-3 · Cited by 597 · see citing works

The link between the GBA gene and parkinsonism

Sidransky, E., & Lopez, G. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70190-4 · Cited by 575 · see citing works

Disclosure of <i>APOE</i> Genotype for Risk of Alzheimer's Disease

Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., Eckert, S. L., Butson, M., Sadovnick, A. D., Quaid, K. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809578 · Cited by 554 · see citing works

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

Reiman, E. M., Quiroz, Y. T., Fleisher, A. S., Chen, K., Velez-Pardo, C., Jimenez-Del-Rio, M., Fagan, A. M., Shah, A. R., Alvarez, S., Arbelaez, A., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70228-4 · Cited by 541 · see citing works

The heritability and genetics of frontotemporal lobar degeneration

Rohrer, J. D., Guerreiro, R., Vandrovcova, J., Uphill, J., Reiman, D., Beck, J., Isaacs, A. M., Authier, A., Ferrari, R., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf997a · Cited by 536 · see citing works

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

Pankratz, N., Wilk, J., Latourelle, J., Destefano, A., Halter, C., Pugh, E., Doheny, K., Gusella, J., Nichols, W., Foroud, T., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0582-9 · Cited by 483 · see citing works

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457 · see citing works

Technical report: ethical and policy issues in genetic testing and screening of children

Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.176 · Cited by 455 · see citing works

The Psychological Consequences of Predictive Testing for Huntington’s Disease

Wiggins, S., Whyte, P., Huggins, M. J., Adam, S., Theilmann, J., Bloch, M., Sheps, S. B., Schechter, M. T., Hayden, M. R., & Testing*, T. C. C. S. O. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272001 · Cited by 452 · see citing works

The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Brinkman, R. R., Mezei, M., Theilmann, J., Almqvist, E. W., & Hayden, M. R. (1997) · Europe PMC (PubMed Central) · Cited by 368 · see citing works

Environmental Enrichment Rescues Protein Deficits in a Mouse Model of Huntington's Disease, Indicating a Possible Disease Mechanism

Spires‐Jones, T. L., Grote, H., Varshney, N. K., Cordery, P. M., van Dellen, A., Blakemore, C. B., & Hannan, A. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1658-03.2004 · Cited by 367 · see citing works

CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches

Langbehn, D. R., Hayden, M. R., Paulsen, J. S., & and the PREDICT‐HD Investigators of the Huntington Study Group (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30992 · Cited by 367 · see citing works

Cognitive Impairment in Huntington Disease: Diagnosis and Treatment

Paulsen, J. S. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0215-x · Cited by 364 · see citing works

Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing

Gershon, R. C., Lai, J. S., Bode, R. K., Choi, S. W., Moy, C. S., Bleck, T., Miller, D. M., Peterman, A. H., & Cella, D. F. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9958-8 · Cited by 361 · see citing works

The genetic testing of children. Working Party of the Clinical Genetics Society (UK)

Clarke, A. J. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.785 · Cited by 357 · see citing works

Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease

Landles, C., Sathasivam, K., Weiss, A., Woodman, B., Moffitt, H., Finkbeiner, S. M., Sun, B., Gafni, J., Ellerby, L., Trottier, Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075028 · Cited by 328 · see citing works

Environmental enrichment slows disease progression in R6/2 Huntington's disease mice

Hockly, E., Cordery, P., Woodman, B., Mahal, A., van Dellen, A., Blakemore, C., Lewis, C., Hannan, A., & Bates, G. (2002) · Annals of Neurology · doi:10.1002/ana.10094 · Cited by 326 · see citing works

Genetic Discrimination: Perspectives of Consumers

Lapham, E. V., Kozma, C., & Weiss, J. O. (1996) · Science · doi:10.1126/science.274.5287.621 · Cited by 318 · see citing works

Guidelines for the molecular genetics predictive test in Huntington's disease

(1994) · Neurology · doi:10.1212/wnl.44.8.1533 · Cited by 310 · see citing works

Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study

Postuma, R. B., Bertrand, J., Montplaisir, J. Y., Desjardins, C., Vendette, M., Romenets, S. R., Panisset, M., & Gagnon, J. (2012) · Movement Disorders · doi:10.1002/mds.24939 · Cited by 307 · see citing works

Genetics of Parkinson's disease and parkinsonism

Hardy, J., Cai, H., Cookson, M., Gwinn, K. A., & Singleton, A. (2006) · Annals of Neurology · doi:10.1002/ana.21022 · Cited by 306 · see citing works

Ethical Principles and Guidelines for the Protection of Human Subjects of Research.

(1979) · PsycEXTRA Dataset · doi:10.1037/e301872003-001 · Cited by 295 · see citing works

A Worldwide Assessment of the Frequency of Suicide, Suicide Attempts, or Psychiatric Hospitalization after Predictive Testing for Huntington Disease

Almqvist, E. W., Bloch, M., Brinkman, R. R., Craufurd, D., & Hayden, M. R. (1999) · The American Journal of Human Genetics · doi:10.1086/302374 · Cited by 287 · see citing works

Pathological correlates of gastrointestinal dysfunction in Parkinson's disease

Cersosimo, M. G., & Benarroch, E. E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.014 · Cited by 284 · see citing works

The Relationship of 60 Disease Diagnoses and 15 Conditions to Preference-Based Health-Related Quality of Life in Ontario Hospital-Based Long-Term Care Residents

Lam, J. M. C., & Wodchis, W. P. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181ca2647 · Cited by 272 · see citing works

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

Farrer, L. A. (1995) · JAMA · doi:10.1001/jama.1995.03530200063039 · Cited by 271 · see citing works

Patient Autonomy and Incidental Findings in Clinical Genomics

Wolf, S. M., Annas, G. J., & Elias, S. (2013) · Science · doi:10.1126/science.1239119 · Cited by 271 · see citing works

US Biomedical Research

Zerhouni, E. A. (2005) · JAMA · doi:10.1001/jama.294.11.1352 · Cited by 256 · see citing works

The differential mediating effects of pain and depression on the physical and mental dimension of quality of life in Hong Kong Chinese adults

Wong, W. S., Chan, T. M. S., Fung, V. B., & Fielding, R. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-1 · Cited by 256 · see citing works

[Measuring quality of life in palliative care].

Ferreira, P. L., Barros, A. P., & Brito, A. B. (2008) · PubMed · Cited by 254 · see citing works

Longitudinal change in regional brain volumes in prodromal Huntington disease

Aylward, E., Nopoulos, P., Ross, C. A., Langbehn, D. R., Pierson, R. K., Mills, J. A., Johnson, H. J., Magnotta, V. A., Juhl, A. R., Paulsen, J. S., et al. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.208264 · Cited by 253 · see citing works

Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers

Borry, P., Stultiëns, L., Nys, H., Cassiman, J.-J., & Dierickx, K. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00692.x · Cited by 251 · see citing works

The complexities of predictive genetic testing

Evans, J. P., Skrzynia, C., & Burke, W. (2001) · British medical journal · doi:10.1136/bmj.322.7293.1052 · Cited by 247 · see citing works

Health Behavior Changes After Genetic Risk Assessment for Alzheimer Disease: The REVEAL Study

Chao, S. H.-L., Roberts, J. S., Marteau, T. M., Silliman, R. A., Cupples, L. A., & Green, R. C. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815a9dcc · Cited by 243 · see citing works

Psychological impact of genetic testing for Huntington's disease: an update of the literature

Meiser, B. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.574 · Cited by 243 · see citing works

Apolipoprotein E genotyping in Alzheimer's disease

Relkin, N. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90284-6 · Cited by 241 · see citing works

The meaning of illness: a phenomenological approach to the patient-physician relationship.

Toombs, S. (1987) · Journal of Medicine and Philosophy · doi:10.1093/jmp/12.3.219 · Cited by 238 · see citing works

Recommendations for the predictive genetic test in Huntington's disease

MacLeod, R., Tibben, A., Frontali, M., Evers‐Kiebooms, G., Jones, A., Martínez‐Descals, A., & Roos, R. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01900.x · Cited by 237 · see citing works

Brain Structure in Preclinical Huntington’s Disease

Paulsen, J. S., Magnotta, V. A., Mikos, A., Paulson, H. L., Penziner, E., Andreasen, N. C., & Nopoulos, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.003 · Cited by 235 · see citing works

Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE

Wijsman, E. M., Pankratz, N., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., Lee, J. H., Bird, T. D., Bennett, D. A., Diaz-Arrastia, R. R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001308 · Cited by 223 · see citing works

Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey

Bombard, Y., Veenstra, G., Friedman, J. M., Creighton, S., Currie, L., Paulsen, J. S., Bottorff, J. L., & Hayden, M. R. (2009) · BMJ · doi:10.1136/bmj.b2175 · Cited by 221 · see citing works

UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASE

Craufurd, D., Kerzin-Storrar, L., Dodge, A., & Harris, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90722-8 · Cited by 218 · see citing works

Sources of Structure: Genetic, Environmental, and Artifactual Influences on the Covariation of Personality Traits

McCrae, R. R., Jang, K. L., Livesley, W. J., Riemann, R., & Angleitner, A. (2001) · Journal of Personality · doi:10.1111/1467-6494.694154 · Cited by 214 · see citing works

Reluctance to undergo predictive testing: The case of Huntington Disease

Quaid, K. A., & Morris, M. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320450112 · Cited by 210 · see citing works

The Neurology Quality-of-Life Measurement Initiative

Cella, D. F., Nowinski, C. J., Peterman, A. H., Victorson, D. E., Miller, D. M., Lai, J., & Moy, C. S. (2011) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2011.01.025 · Cited by 207 · see citing works

The Genetic Information Nondiscrimination Act of 2008

Donald, C. G., & Sanders, A. K. (2008) · Journal of Diversity Management (JDM) · doi:10.19030/jdm.v3i4.5000 · Cited by 205 · see citing works

Clinical markers of early disease in persons near onset of Huntington’s disease

Paulsen, J. S., Zhao, H., Stout, J. C., Brinkman, R. R., Guttman, M., Ross, C. A., Como, P. G., Manning, C. A., Hayden, M. R., Shoulson, I., et al. (2001) · Neurology · doi:10.1212/wnl.57.4.658 · Cited by 204 · see citing works

The Clinical Introduction of Genetic Testing for Alzheimer Disease An Ethical Perspective

Post, S. G. (1997) · JAMA · doi:10.1001/jama.277.10.832 · Cited by 204 · see citing works

International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease.

(1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.7.555 · Cited by 204 · see citing works

Measuring quality of life in palliative care.

Cella, D. F. (1995) · PubMed · Cited by 201 · see citing works

Thalamic metabolism and symptom onset in preclinical Huntington's disease

Feigin, A., Tang, C., Ma, Y., Mattis, P. J., Zgaljardic, D. J., Guttman, M., Paulsen, J. S., DHAWAN, V. M., & Eidelberg, D. (2007) · Brain · doi:10.1093/brain/awm217 · Cited by 201 · see citing works

Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease

Johnson, H. J., Stout, J. C., Solomon, A. C., Langbehn, D. R., Aylward, E., Cruce, C. B., Ross, C. A., NANCE, M. A., Kayson, E., Julian-Baros, E., et al. (2007) · Brain · doi:10.1093/brain/awm107 · Cited by 195 · see citing works

Attitudes of persons at risk for Huntington disease toward predictive testing

Kessler, S., Field, T., Worth, L. L., Mosbarger, H., Opitz, J. M., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320260204 · Cited by 194 · see citing works

Quality of Life in Rare Genetic Conditions: A Systematic Review of the Literature

Cohen, J., & Biesecker, B. B. (2010) · American Journal of Medical Genetics. Part A · doi:10.1002/ajmg.a.33380 · Cited by 193 · see citing works

Behavioural abnormalities contribute to functional decline in Huntington's disease

Hamilton, J. M. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.120 · Cited by 184 · see citing works

Psychological costs and benefits of predictive testing for Huntington's disease

Codori, A., & Brandt, J. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320540304 · Cited by 179 · see citing works

Genetics and Epigenetics of Parkinson's Disease

Coppedè, F. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/489830 · Cited by 175 · see citing works

Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment

Lazic, S. E., Grote, H., Blakemore, C. B., Hannan, A. J., van Dellen, A., Phillips, W., & Barker, R. A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04715.x · Cited by 172 · see citing works

Ethics and Genomic Incidental Findings

McGuire, A. L., Joffe, S., Koenig, B. A., Biesecker, B. B., McCullough, L. B., Blumenthal‐Barby, J. S., Caulfield, T., Terry, S. F., & Green, R. C. (2013) · Science · doi:10.1126/science.1240156 · Cited by 172 · see citing works

The influence of cognitive impairment on health-related quality of life in neurological disease

Mitchell, A. J., Kemp, S., Benito‐León, J., & Reuber, M. (2010) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00439.x · Cited by 171 · see citing works

Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease

Labbadia, J. P., Cunliffe, H. E., Weiss, A., Katsyuba, E., Sathasivam, K., Seredenina, T. S., Woodman, B., Moussaoui, S. M., Frentzel, S., Luthi‐Carter, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57413 · Cited by 171 · see citing works

Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics

Recommendations of the European Society of Human Genetics (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.26 · Cited by 167 · see citing works

Attitudes toward presymptomatic testing in Huntington disease

Mastromauro, C. A., Myers, R. H., Berkman, B., Opitz, J. M., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320260205 · Cited by 167 · see citing works

Predictive testing for Huntington disease in Canada: The experience of those receiving an increased risk

Bloch, M., Adam, S., Wiggins, S., Huggins, M. J., & Hayden, M. R. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320420416 · Cited by 164 · see citing works

Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease

Djoussé, L., Knowlton, B. A., Hayden, M. R., Almqvist, E. W., Brinkman, R. R., Ross, C. A., Margolis, R. L., Rosenblatt, A., Dürr, A., Dodé, C., et al. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20190 · Cited by 162 · see citing works

Genetic Information Nondiscrimination Act

Funke, R. D., Dillard, B., Potthast, A., Boxall, S. F., Carr, E., Carr, S., Diaz-Sprague, R., Elliott, D. L., England, R., & Price, C. (2008) · Ethics & Behavior · Cited by 161 · see citing works

Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease

Aziz, N. A., Anguelova, G. V., Marinus, J., Lammers, G. J., & Roos, R. A. C. (2010) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2010.02.009 · Cited by 155 · see citing works

Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.

Tibben, A., Timman, R., Bannink, E. C., & Duivenvoorden, H. J. (1997) · Health Psychology · doi:10.1037//0278-6133.16.1.20 · Cited by 151 · see citing works

Health‐related quality of life in Huntington's disease: Which factors matter most?

Ho, A. K., Gilbert, A. S., Mason, S., Goodman, A. O., & Barker, R. A. (2008) · Movement Disorders · doi:10.1002/mds.22412 · Cited by 150 · see citing works

Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study

Biglan, K., Ross, C. A., Langbehn, D. R., Aylward, E., Stout, J. C., Queller, S., Carlozzi, N. E., Duff, K., Beglinger, L. J., & Paulsen, J. S. (2009) · Movement Disorders · doi:10.1002/mds.22601 · Cited by 146 · see citing works

Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression

the EORTC Quality of Life Group and the Quality of Life Cross-Cultural Meta-Analysis Group, SCOTT, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., de Graeff, A., Grøenvold, M., Gundy, C. M., Koller, M. T., Petersen, M. A., et al. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-81 · Cited by 146 · see citing works

Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology.

Went, L. N. (1990) · Journal of Medical Genetics · doi:10.1136/jmg.27.1.34 · Cited by 143 · see citing works

Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QOL) measurement system

Salsman, J. M., Victorson, D. E., Choi, S. W., Peterman, A. H., Heinemann, A. W., Nowinski, C. J., & Cella, D. F. (2013) · Quality of Life Research · doi:10.1007/s11136-013-0382-0 · Cited by 141 · see citing works

Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents

Neumann, P. J., Cohen, J. T., Hammitt, J. K., Concannon, T. W., Auerbach, H. R., Fang, C., & Kent, D. M. (2010) · Health Economics · doi:10.1002/hec.1704 · Cited by 141 · see citing works

Predictive testing for Huntington's disease

Tibben, A. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.023 · Cited by 140 · see citing works

The Multiple Faces of Valosin-Containing Protein-Associated Diseases: Inclusion Body Myopathy with Paget’s Disease of Bone, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis

Nalbandian, A., Donkervoort, S. C., Dec, E., Badadani, M., Katheria, V., Rana, P., Nguyen, C. C., Mukherjee, J., Caiozzo, V. J., Martin, B., et al. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9627-y · Cited by 137 · see citing works

Delayed onset of huntington′s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors

Glass, M., van Dellen, A., Blakemore, C. B., Hannan, A. J., & Faull, R. L. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00595-5 · Cited by 136 · see citing works

The chromosome 9 ALS and FTD locus is probably derived from a single founder

Mok, K., Traynor, B. J., Schymick, J., Tienari, P. J., Laaksovirta, H., Peuralinna, T., Myllykangas, L., Chiò, A., Shatunov, A., Boeve, B. F., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.005 · Cited by 131 · see citing works

Predictive testing for Huntington disease: interpretation and significance of intermediate alleles

Semaka, A., Creighton, S., Warby, S. C., & Hayden, M. R. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00668.x · Cited by 129 · see citing works

Genetics of Parkinson disease

Pankratz, N., & Foroud, T. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31815bf97c · Cited by 125 · see citing works

Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease

Almqvist, E. W., Brinkman, R. R., Wiggins, S., Hayden, M. R., & Testing, T. C. C. S. O. P. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00157.x · Cited by 125 · see citing works

At‐risk Persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan

Markel, D. S., Young, A. B., Penney, J. B., Opitz, J. M., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320260207 · Cited by 122 · see citing works

Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.

Decruyenaere, M., Evers‐Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., Dom, R., Fryns, J. P., & BERGHE, H. V. D. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.9.737 · Cited by 120 · see citing works

Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.

Tibben, A., Timman, R., Bannink, E. C., et al. (1997) · Health Psychology · doi:10.1037/0278-6133.16.1.20 · Cited by 118 · see citing works

Psychological distress in the 5-year period after predictive testing for Huntington's disease

Decruyenaere, M., Evers‐Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., Dom, R., & Fryns, J. P. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200913 · Cited by 117 · see citing works

Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial

Roberts, J. S., Barber, M., Brown, T., Cupples, L. A., Farrer, L. A., LaRusse, S., Post, S. G., Quaid, K. A., Ravdin, L., Relkin, N. R., et al. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000132688.55591.77 · Cited by 113 · see citing works

Adverse Effects of Predictive Testing for Huntington Disease Underestimated: Long-Term Effects 7-10 Years After the Test.

Timman, R., Roos, R. A. C., Maat‐Kievit, A., & Tibben, A. (2004) · Health Psychology · doi:10.1037/0278-6133.23.2.189 · Cited by 113 · see citing works

Long-term outcome of presymptomatic testing in Huntington disease

Gargiulo, M., Lejeune, S., Tanguy, M., Lahlou‐Laforêt, K., Faudet, A., Cohen, D., Feingold, J., & Dürr, A. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.146 · Cited by 113 · see citing works

Carrier testing in minors: a systematic review of guidelines and position papers

Borry, P., Fryns, J., Schotsmans, P. T., & Dierickx, K. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201509 · Cited by 112 · see citing works

The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education

Evers‐Kiebooms, G., Welkenhuysen, M., Claes, E., Decruyenaere, M., & Denayer, L. (2000) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00064-2 · Cited by 111 · see citing works

Functional imaging in Huntington's disease

Paulsen, J. S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.015 · Cited by 109 · see citing works

On attitudes and appreciation 6 months after predictive DNA testing for huntington disease in the Dutch program

Tibben, A., Frets, P. G., van de Kamp, J. J. P., Niermeijer, M. F., der Vlis, M. V.-V., Roos, R. A. C., Rooymans, H. G. M., van Ommen, G. B., & Verhage, F. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480209 · Cited by 108 · see citing works

Impact of DNA Testing for Early-Onset Familial Alzheimer Disease and Frontotemporal Dementia

Steinbart, E. J. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1828 · Cited by 107 · see citing works

Concerns in a primary care population about genetic discrimination by insurers

Hall, M. A., McEwen, J. E., Barton, J. C., Walker, A. P., Howe, E. G., Reiss, J. A., Power, T. E., Ellis, S. D., Tucker, D. C., Harrison, B. W., et al. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000162874.58370.c0 · Cited by 106 · see citing works

Clinical prediction of Parkinson's disease: planning for the age of neuroprotection

Postuma, R. B., Gagnon, J., & Montplaisir, J. Y. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.174748 · Cited by 106 · see citing works

To know or not to know: A review of behaviour and suicidal ideation in preclinical Huntington's disease

Wahlin, T. R. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2006.08.009 · Cited by 105 · see citing works

Wilson disease—A practical approach to diagnosis, treatment and follow-up

Medici, V., Rossaro, L., & Sturniolo, G. C. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.12.095 · Cited by 100 · see citing works

International Literature Review on WHODAS II (World Health Organization Disability Assessment Schedule II)

Federici, S., Meloni, F., & Lo Presti, A. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 100 · see citing works

Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease

Farrer, L. A., Brin, M. F., Elsas, L. J., Goate, A., Kennedy, J. L., Mayeux, R. P., Myers, R. H., Reilly, P. M., & RISCH, N. J. (1995) · JAMA · doi:10.1001/jama.274.20.1627 · Cited by 100 · see citing works

Presymptomatic DNA‐testing for Huntington disease: Pretest attitudes and expectations of applicants and their partners in the Dutch program

Tibben, A., Frets, P. G., van de Kamp, J. J. P., Niermeijer, M. F., der Vlis, M. V.-V., Roos, R. A. C., van Ommen, G. B., Duivenvoorden, H. J., & Verhage, F. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480105 · Cited by 96 · see citing works

Predictors of psychological adjustment to genetic testing for Huntington's disease.

Codori, A., Slavney, P. R., Young, C., Miglioretti, D. L., & Brandt, J. (1997) · Health Psychology · doi:10.1037/0278-6133.16.1.36 · Cited by 94 · see citing works

Presymptomatic DNA testing for Huntington disease: Identifying the need for psychological intervention

Tibben, A., Duivenvoorden, H. J., der Vlis, M. V.-V., Niermeijer, M. F., Frets, P. G., van de Kamp, J. J. P., Roos, R. A. C., Rooijmans, H. G. M., & Verhage, F. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480305 · Cited by 91 · see citing works

Daytime somnolence and nocturnal sleep disturbances in Huntington disease

Videnović, A., Leurgans, S. E., Fan, W., Jaglin, J., & Shannon, K. M. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.10.002 · Cited by 90 · see citing works

Early detection of Huntington‘s disease

Paulsen, J. S. (2009) · Future Neurology · doi:10.2217/fnl.09.78 · Cited by 90 · see citing works

Application of the National Institutes of Health Patient-reported Outcome Measurement Information System (PROMIS) to mental health research.

Riley, W. T., Pilkonis, P. A., & Cella, D. F. (2011) · PubMed · Cited by 89 · see citing works

Investigating genetic discrimination in Australia: a large‐scale survey of clinical genetics clients

Taylor, S. D., Treloar, S. A., Barlow-Stewart, K. K., Stranger, M., & Otlowski, M. F. A. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01016.x · Cited by 86 · see citing works

Guidelines for the Ethical, Social and Legal Issues in Prenatal Diagnosis

Powledge, T. M., & Fletcher, J. C. (1979) · New England Journal of Medicine · doi:10.1056/nejm197901253000404 · Cited by 86 · see citing works

Self-paced timing detects and tracks change in prodromal Huntington disease.

Rowe, K. C., PREDICT-HD Investigators of the Huntington Study Group, Paulsen, J. S., Langbehn, D. R., Duff, K., Beglinger, L. J., Wang, C., O’Rourke, J. J. F., Stout, J. C., & Moser, D. J. (2010) · Neuropsychology · doi:10.1037/a0018905 · Cited by 85 · see citing works

Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice

Schilling, G., Savonenko, A. V., Coonfield, M. L., Morton, J. L., Vorovich, E. B., Gale, A., Neslon, C., Chan, N., Eaton, M., Fromholt, D., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.003 · Cited by 85 · see citing works

Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea.

Tyler, A., & Harper, P. S. (1983) · Journal of Medical Genetics · doi:10.1136/jmg.20.3.179 · Cited by 84 · see citing works

Recent Advances in the Genetics of Cerebellar Ataxias

Sailer, A., & Houlden, H. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0267-6 · Cited by 83 · see citing works

Refining the diagnosis of Huntington disease: the PREDICT-HD study

Biglan, K. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00012 · Cited by 83 · see citing works

Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP

Mead, S., Uphill, J. B., Beck, J., Poulter, M., Campbell, T., Lowe, J., Adamson, G., Hummerich, H., Klopp, N., Rückert, I., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr607 · Cited by 83 · see citing works

Clinical and Pathological Overlap between Frontotemporal Dementia, Primary Progressive Aphasia and Corticobasal Degeneration: The Pick Complex

KERTESZ, A. E., Davidson, W., & Muñoz, D. G. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051212 · Cited by 82 · see citing works

An international survey of predictive genetic testing in children for adult onset conditions

Duncan, R. E., Savulescu, J., Gillam, L. H., Williamson, R., & Delatycki, M. B. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000170775.39092.44 · Cited by 81 · see citing works

A de novo missense mutation of the FUS gene in a “true” sporadic ALS case

Chiò, A., Calvo, A., Moglia, C., Ossola, I., Brunetti, M., Sbaiz, L., Lai, S.-L., Abramzon, Y. A., Traynor, B. J., & Restagno, G. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.016 · Cited by 79 · see citing works

Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients

Apse, K. A., Biesecker, B. B., Giardiello, F. M., Fuller, B. P., & Bernhardt, B. A. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000144013.96456.6c · Cited by 78 · see citing works

An algorithm for genetic testing of frontotemporal lobar degeneration

Goldman, J. S., Rademakers, R., Huey, E. D., Boxer, A. L., Mayeux, R. P., Miller, B. L., & Boeve, B. F. (2011) · Neurology · doi:10.1212/wnl.0b013e31820a0d13 · Cited by 78 · see citing works

Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: Comparing questionnaire results with in-depth interviews

DudokdeWit, A. C., Tibben, A., Duivenvoorden, H. J., Niermeijer, M. F., Passchier, J., Trijsburg, R. W., & Workgroup, T. R. G. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980106)75:1 · Cited by 78 · see citing works

Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease

Carlozzi, N. E., & Tulsky, D. S. (2012) · Journal of Health Psychology · doi:10.1177/1359105312438109 · Cited by 77 · see citing works

A Comparison of Mood and Quality of Life Among People with Progressive Neurological Illnesses and Their Caregivers

McCabe, M. P., Firth, L., & O’Connor, E. (2009) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-009-9168-5 · Cited by 76 · see citing works

Experience over fifteen years with a protocol for predictive testing for Huntington disease

Dufrasne, S., Roy, M., Gálvez, M. C. C., & Rosenblatt, D. S. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.12.001 · Cited by 75 · see citing works

Genetic risk of Alzheimer's disease: advising relatives

Liddell, M. B., Lovestone, S., & Owen, M. J. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.1.7 · Cited by 74 · see citing works

Using Focus Groups To Inform the Neuro-QOL Measurement Tool: Exploring Patient-Centered, Health-Related Quality of Life Concepts Across Neurological Conditions

Perez, L. V., Huang, J. C., Jansky, L. J., Nowinski, C. J., Victorson, D. E., Peterman, A. H., & Cella, D. F. (2007) · Journal of Neuroscience Nursing · doi:10.1097/01376517-200712000-00005 · Cited by 74 · see citing works

Postgenomics, uncertain futures, and the familiarization of susceptibility genes

Chilibeck, G., Lock, M. M., & Sehdev, M. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2010.01.053 · Cited by 74 · see citing works

Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease

Babul, R. (1993) · JAMA · doi:10.1001/jama.270.19.2321 · Cited by 74 · see citing works

Ethnic differences in the expression of neurodegenerative disease: Machado‐Joseph disease in Africans and Caucasians

Subramony, S. H., Hernandez, D. G., Adam, A., Smith‐Jefferson, S., Hussey, J., Gwinn, K. A., Lynch, T., McDaniel, O. D., Hardy, J., Farrer, M. J., et al. (2002) · Movement Disorders · doi:10.1002/mds.10241 · Cited by 73 · see citing works

Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.

Lawson, K., Wiggins, S., Green, T., Adam, S., Bloch, M., & Hayden, M. R. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.10.856 · Cited by 72 · see citing works

8OHdG as a marker for Huntington disease progression

Long, J. D., Matson, W. R., Juhl, A. R., Leavitt, B. R., & Paulsen, J. S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.02.012 · Cited by 71 · see citing works

Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians

Lowstuter, K. J., Sand, S. R., Blazer, K. R., MacDonald, D. J., Banks, K. C., Lee, C. A., Schwerin, B. U., Juarez, M., Uman, G. C., & Weitzel, J. N. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e3181837246 · Cited by 69 · see citing works

Why test children for adult-onset genetic diseases?

Rhodes, R. (2006) · PubMed · Cited by 68 · see citing works

The motivation of at‐risk individuals and their partners in deciding for or against predictive testing for Huntington's disease

Evers‐Kiebooms, G., Swerts, A., Cassiman, J. J., & BERGHE, H. V. D. (1989) · Clinical Genetics · doi:10.1111/j.1399-0004.1989.tb02902.x · Cited by 68 · see citing works

Predicting Parkinson's disease – why, when, and how?

Postuma, R. B., & Montplaisir, J. Y. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70793-x · Cited by 67 · see citing works

Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea.

(1994) · PubMed · Cited by 67 · see citing works

Impact of Huntington's across the entire disease spectrum: the phases and stages of disease from the patient perspective

Ho, A., Hocaoğlu, M., & for the European Huntington's Disease Network Quality of Life Working Group (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01748.x · Cited by 66 · see citing works

Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease

Bombard, Y., Penziner, E., Suchowersky, O., Guttman, M., Paulsen, J. S., Bottorff, J. L., & Hayden, M. R. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201937 · Cited by 66 · see citing works

Decrease in lipid peroxidation measured by breath pentane output in normals after oral supplementation with vitamin E

Gossum, A. V., Kurian, R., Whitwell, J., & Jeejeebhoy, K. N. (1988) · Clinical Nutrition · doi:10.1016/0261-5614(88)90012-x · Cited by 66 · see citing works

Ethical issues policy statement on Huntington's disease molecular genetics predictive test

(1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90243-8 · Cited by 66 · see citing works

Predictors of quality of life in carers for people with a progressive neurological illness: a longitudinal study

O’Connor, E. J., & McCabe, M. P. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9804-4 · Cited by 65 · see citing works

Unstable familial transmissions of Huntington disease alleles with 27–35 CAG repeats (intermediate alleles)

Semaka, A., Collins, J. A., & Hayden, M. R. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30970 · Cited by 65 · see citing works

Health‐related quality of life in Huntington's disease: A comparison of two generic instruments, SF‐36 and SIP

Ho, A. K., Robbins, A. O. G., Walters, S. J., Kaptoge, S. K., Sahakian, B. J., & Barker, R. A. (2004) · Movement Disorders · doi:10.1002/mds.20208 · Cited by 65 · see citing works

A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder

Bogaerts, V., Engelborghs, S., Kumar‐Singh, S., Goossens, D., Pickut, B. A., van der Zee, J., Sleegers, K., Peeters, K., Martin, J., Del‐Favero, J., et al. (2007) · Brain · doi:10.1093/brain/awm167 · Cited by 65 · see citing works

Genetic testing in Parkinson's disease

McInerney-Leo, A. M., Hadley, D. W., Gwinn, K. A., & Hardy, J. (2004) · Movement Disorders · doi:10.1002/mds.20316 · Cited by 64 · see citing works

Cognitive and Psychiatric Aspects of Huntington Disease Contribute to Functional Capacity

Nehl, C., & Paulsen, J. S. (2003) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000106004.67587.57 · Cited by 63 · see citing works

The Spinocerebellar Ataxias: Clinical Aspects And Molecular Genetics

Matilla‐Dueñas, A., Corral‐Juan, M., Volpini, V., & Sánchez, I. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_27 · Cited by 61 · see citing works

Perception, experience, and response to genetic discrimination in Huntington disease: The international RESPOND‐HD study

Erwin, C. J., Williams, J. K., Juhl, A. R., Mengeling, M. A., Mills, J. A., Bombard, Y., Hayden, M. R., Quaid, K. A., Shoulson, I., Taylor, S. D., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31079 · Cited by 61 · see citing works

Biobanks: Importance, Implications and Opportunities for Genetic Counselors

Hawkins, A. K. (2010) · Journal of Genetic Counseling · doi:10.1007/s10897-010-9305-1 · Cited by 60 · see citing works

Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues

Roberts, J. S., & Uhlmann, W. R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.02.005 · Cited by 60 · see citing works

Genetic Privacy Laws and Patients' Fear of Discrimination by Health Insurers: The View from Genetic Counselors

Hall, M. A., & Rich, S. S. (2000) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2000.tb00668.x · Cited by 60 · see citing works

Reflexive and volitional saccades: Biomarkers of Huntington disease severity and progression

Patel, S. S., Jankovic, J. J., Hood, A. J., Jeter, C. B., & Sereno, A. B. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.035 · Cited by 59 · see citing works

Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS

DeJesus-Hernandez, M., Desaro, P., Johnston, A., Ross, O. A., Wszolek, Z. K., Ertekin-Taner, N., Graff-Radford, N. R., Rademakers, R., & Boylan, K. (2011) · Neurology · doi:10.1212/wnl.0b013e31822e563c · Cited by 55 · see citing works

Predictive Genetic Testing for Alzheimer's Disease: Impact upon Risk Perception

Marteau, T. M., Roberts, J. S., LaRusse, S., & Green, R. C. (2005) · Risk Analysis · doi:10.1111/j.1539-6924.2005.00598.x · Cited by 54 · see citing works

In their own words: Reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND‐HD study

Williams, J. K., Erwin, C. J., Juhl, A. R., Mengeling, M. A., Bombard, Y., Hayden, M. R., Quaid, K. A., Shoulson, I., Taylor, S. D., Paulsen, J. S., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31080 · Cited by 54 · see citing works

Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease

Penziner, E., Williams, J. K., Erwin, C. J., Bombard, Y., Wallis, A. B., Beglinger, L. J., Hayden, M. R., & Paulsen, J. S. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30600 · Cited by 53 · see citing works

Genetics of Dementia

Paulson, H. L., & Igo, I. S. (2011) · Seminars in Neurology · doi:10.1055/s-0031-1299784 · Cited by 52 · see citing works

Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease

Decruyenaere, M., Evers‐Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., Dom, R., & Fryns, J. P. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.12.897 · Cited by 52 · see citing works

Quality of life, anxiety and depression in ALS patients and their next of kin

Ozanne, A., Strang, S., & Persson, L. (2010) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2010.03509.x · Cited by 52 · see citing works

Biomarkers of aging

Bao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 389 · see citing works

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramı́rez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 308 · see citing works

Depression in neurodegenerative diseases: Common mechanisms and current treatment options

Galts, C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil‐Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 268 · see citing works

Multi-modality machine learning predicting Parkinson’s disease

Makarious, M. B., Leonard, H. L., Vitale, D., Iwaki, H., Sargent, L. J., Dadu, A., Violich, I., Hutchins, E. D., Saffo, D., Bandrés‐Ciga, S., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00288-w · Cited by 188 · see citing works

The Patterns of Inheritance in Early-Onset Dementia

Jarmolowicz, A. I., Chen, H.-Y., & Panegyres, P. K. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514545825 · Cited by 87 · see citing works

Cognitive and behavioral changes in Huntington disease before diagnosis

Paulsen, J. S., Miller, A. C., Hayes, T., & Shaw, E. E. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801893-4.00006-7 · Cited by 83 · see citing works

Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities

Puckett, Y., Mallorga-Hernández, A., & Montaño, A. M. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01880-8 · Cited by 73 · see citing works

The Value of Diagnostic Information in Personalised Healthcare: A Comprehensive Concept to Facilitate Bringing This Technology into Healthcare Systems

Wurcel, V., Cicchetti, A., Garrison, L. P., Kip, M. M. A., Koffijberg, H., Kolbe, A., Leeflang, M., Merlin, T., Mestre‐Ferrandiz, J., Oortwijn, W., et al. (2019) · Public Health Genomics · doi:10.1159/000501832 · Cited by 72 · see citing works

Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials

Kim, S. Y. H., Karlawish, J. H., & Berkman, B. E. (2015) · Neurology · doi:10.1212/wnl.0000000000001451 · Cited by 70 · see citing works

A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease

Vinther‐Jensen, T., Larsen, I. U., Hjermind, L. E., Budtz–Jørgensen, E., Nielsen, T. T., Nørremølle, A., Nielsen, J. E., & Vogel, A. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-014-0114-8 · Cited by 69 · see citing works

Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review

van der Schaar, J., Visser, L. N. C., Bouwman, F. H., Ket, J. C. F., Scheltens, P., Bredenoord, A. L., & van der Flier, W. M. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00971-3 · Cited by 68 · see citing works

Tetramethylpyrazine inhibits CoCl2‐induced neurotoxicity through enhancement of Nrf2/GCLc/GSH and suppression of HIF1α/NOX2/ROS pathways

Guan, D., Su, Y., Li, Y., Wu, C., Yi, M., Peng, X., & Cui, Y. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13161 · Cited by 66 · see citing works

Onset of Huntington's disease: Can it be purely cognitive?

Paulsen, J. S., & Long, J. D. (2014) · Movement Disorders · doi:10.1002/mds.25997 · Cited by 63 · see citing works

Pioglitazone attenuates lipopolysaccharide-induced depression-like behaviors, modulates NF-κB/IL-6/STAT3, CREB/BDNF pathways and central serotonergic neurotransmission in mice

Liao, L., Zhang, X. D., Li, J., Zhang, Z. W., Yang, C., Rao, C., Zhou, C., Zeng, L., Zhao, L., Fang, L., et al. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.036 · Cited by 63 · see citing works

Lycium barbarum polysaccharide protects against neurotoxicity via the Nrf2‑HO‑1 pathway

Cao, S., Du, J., & Hei, Q. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5127 · Cited by 63 · see citing works

Exposure to Ambient Air Particles Increases the Risk of Mental Disorder: Findings from a Natural Experiment in Beijing

Jia, Z., Wei, Y., Li, X., Yang, L., Liu, H., Guo, C., Zhang, L., Li, N., Guo, S., Qian, Y., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010160 · Cited by 62 · see citing works

P5 eHealth: An Agenda for the Health Technologies of the Future

Pravettoni, G., & Triberti, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-27994-3 · Cited by 62 · see citing works

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)

Carlozzi, N. E., Schilling, S. G., Lai, J., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., Ross, C. A., Downing, N. R., Kratz, A. L., McCormack, M. K., et al. (2016) · Quality of Life Research · doi:10.1007/s11136-016-1386-3 · Cited by 58 · see citing works

Quality of Life in Patients with Neurodegenerative Diseases

Batista, P., & Pereira, A. (2016) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.100074 · Cited by 56 · see citing works

MicroSweat: A wearable microfluidic patch for noninvasive and reliable sweat collection enables human stress monitoring

Shajari, S., Salahandish, R., Zare, A., Hassani, M., Moossavi, S., Munro, E., Rashid, R., Rosenegger, D., Bains, J. S., & Sanati Nezhad, A. (2023) · Advanced Science · doi:10.1002/advs.202204171 · Cited by 55 · see citing works

Patients' views on the ethical challenges of early Parkinson disease detection

Schaeffer, E., Rogge, A., Nieding, K., Helmker, V., Letsch, C., Hauptmann, B., & Berg, D. (2020) · Neurology · doi:10.1212/wnl.0000000000009400 · Cited by 52 · see citing works

Towards Modern-Age Advanced Sensors for the Management of Neurodegenerative Disorders: Current Status, Challenges and Prospects

Gautam, A. (2022) · ECS Sensors Plus · doi:10.1149/2754-2726/ac973e · Cited by 50 · see citing works

Genetic Testing and Counseling in the Diagnosis and Management of Young-Onset Dementias

Goldman, J. S. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.01.008 · Cited by 50 · see citing works

Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer’s Disease and Vascular Dementia: A Cross-Sectional Study

Wang, R., Chen, Z., Fu, Y., Wei, X., Liao, J., Liu, X., He, B., Xu, Y., Zou, J., Yang, X., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00026 · Cited by 50 · see citing works

Emerging roles for high‐density lipoproteins in neurodegenerative disorders

Bahrami, A., Barreto, G. E., Lombardi, G., Pirro, M., & Sahebkar, A. (2019) · BioFactors · doi:10.1002/biof.1541 · Cited by 48 · see citing works

siRNA Therapeutics: Future Promise for Neurodegenerative Diseases

Amiri, A., Barreto, G. E., Sathyapalan, T., & Sahebkar, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210402104054 · Cited by 45 · see citing works

Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations

Crook, A., Williams, K. L., Adams, L., Blair, I. P., & Rowe, D. B. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1332079 · Cited by 44 · see citing works

Application of Nanomedicine to the CNS Diseases

Carradori, D., Gaudin, A., Brambilla, D., & Andrieux, K. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.002 · Cited by 39 · see citing works

Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases

Talebi, M., Talebi, M., Kakouri, E., Farkhondeh, T., Pourbagher‐Shahri, A. M., Tarantilis, P. Α., & Samarghandian, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.042 · Cited by 39 · see citing works

Risk Disclosure in Prodromal Parkinson's Disease

Schaeffer, E., Toedt, I., Köhler, S., Rogge, A., & Berg, D. (2021) · Movement Disorders · doi:10.1002/mds.28723 · Cited by 40 · see citing works

Cost-Utility of Using Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia

Handels, R. L. H., Wimo, A. B., Dodel, R. C., Kramberger, M. G., Visser, P. J., Molinuevo, J. L., Verhey, F. R. J., & Winblad, B. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170324 · Cited by 39 · see citing works

Next Generation Sequencing Analysis in Early Onset Dementia Patients

Bonvicini, C., Initiative, A. D. N., Scassellati, C., Benussi, L., Maria, E. D., Maj, C., Ciani, M., Fostinelli, S., Mega, A., Bocchetta, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180482 · Cited by 36 · see citing works

Genetic counseling for prion disease: Updates and best practices

Goldman, J. S., & Vallabh, S. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.06.003 · Cited by 37 · see citing works

Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers

Song, J., Cho, E., Lee, H., Lee, S., Kim, S., & Kim, J. (2025) · Biosensors · doi:10.3390/bios15020102 · Cited by 37 · see citing works

Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review

Carlozzi, N. E., Miciura, A. L., Migliore, N., & Dayalu, P. (2014) · Journal of Huntington s Disease · doi:10.3233/jhd-140115 · Cited by 34 · see citing works

Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases

Scotti, L., & Scotti, L. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610143510 · Cited by 33 · see citing works

Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson’s disease

Acquarone, M., de Melo, T. M., Meireles, F., Brito‐Moreira, J., de Oliveira, G. M., Ferreira, S. T., Castro, N. G., Tovar-Moll, F. F., Houzel, J., & Rehen, S. K. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00097 · Cited by 32 · see citing works

Ethical Implications of Alzheimer’s Disease Prediction in Asymptomatic Individuals through Artificial Intelligence

Ursin, F., Timmermann, C., & Steger, F. (2021) · Diagnostics · doi:10.3390/diagnostics11030440 · Cited by 34 · see citing works

Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6

Cook, A. A., Jayabal, S., Sheng, J., Fields, E., Leung, T. C. S., Quilez, S., McNicholas, E., Lau, L., Huang, S., & Watt, A. J. (2022) · Science Advances · doi:10.1126/sciadv.abh3260 · Cited by 32 · see citing works

The Many Facets of Unawareness in Huntington Disease

McCusker, E. A., & Loy, C. T. (2014) · PubMed Central · doi:10.7916/d8fj2fd3 · Cited by 31 · see citing works

The Arch Electrode: A Novel Dry Electrode Concept for Improved Wearing Comfort

Vasconcelos, B., Fiedler, P., Machts, R., Haueisen, J., & Fonseca, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.748100 · Cited by 30 · see citing works

Quality of life of patients with Parkinson's disease and neurodegenerative dementia: A nationally representative study

Chekani, F., Bali, V., & Aparasu, R. R. (2015) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2015.09.007 · Cited by 30 · see citing works

Science and Suffering: Genetics and the Lived Experience of Illness

Halpin, M. (2017) · Social Problems · doi:10.1093/socpro/spw057 · Cited by 28 · see citing works

Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD

Crook, A., Jacobs, C., Newton-John, T. R. O., Richardson, E., & McEwen, A. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000458 · Cited by 27 · see citing works

Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease

Birolini, G., Valenza, M., Ottonelli, I., Talpo, F., Minoli, L., Cappelleri, A., Bombaci, M., Caccia, C., Canevari, C., Trucco, A., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106823 · Cited by 26 · see citing works

Ethical Considerations in Screening for Rapid Eye Movement Sleep Behavior Disorder in the General Population

Dommershuijsen, L. J., Darweesh, S. K. L., Luik, A. I., Kieboom, B. C. T., Koudstaal, P. J., Boon, A. J. W., Ikram, M. A., Ikram, M. K., & Bunnik, E. M. (2020) · Movement Disorders · doi:10.1002/mds.28262 · Cited by 26 · see citing works

Biomarker-Based Risk Prediction of Alzheimer’s Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

Rostamzadeh, A., Schwegler, C., Gil‐Navarro, S., Rosende‐Roca, M., Romotzky, V., Ortega, G., Cañabate, P., Moreno, M., Schmitz‐Luhn, B., Boada, M., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200484 · Cited by 25 · see citing works

Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead

Lake, J., Storm, C. S., Makarious, M. B., & Bandrés‐Ciga, S. (2021) · Cells · doi:10.3390/cells10051030 · Cited by 24 · see citing works

The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure

Pérez‐Carbonell, L., Simonet, C., Chohan, H., Gill, A., Leschziner, G. D., Schrag, A. E., & Noyce, A. J. (2023) · Movement Disorders · doi:10.1002/mds.29403 · Cited by 24 · see citing works

Exosome-mediated therapeutic delivery: A new horizon for human neurodegenerative disorders’ treatment (with a focus on siRNA delivery improvement)

Seyfizadeh, N., Seyfizadeh, N., Borzoueisileh, S., Elahimanesh, F., Hosseini, V., & Nouri, M. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.06.025 · Cited by 23 · see citing works

Predictive Precision Medicine: Towards the Computational Challenge

Tuena, C., Semonella, M., Fernández‐Álvarez, J., Colombo, D., & Cipresso, P. (2019) · Springer eBooks · doi:10.1007/978-3-030-27994-3_5 · Cited by 23 · see citing works

Communicating 5-Year Risk of Alzheimer’s Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results

Mozersky, J. T., Hartz, S. M., Linnenbringer, E. L., Levin, L., Streitz, M. L., Stock, K., Moulder, K. L., & Morris, J. C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200993 · Cited by 22 · see citing works

Into the Prodrome: Diagnosis, Disadvantage, and Biomedical Ambiguity

Halpin, M. (2020) · Society and Mental Health · doi:10.1177/2156869320912456 · Cited by 21 · see citing works

Health-Related Quality of Life Assessment in Children Followed in a Cardiomyopathy Clinic

Friess, M. R., Marino, B. S., Cassedy, A. E., Wilmot, I., Jefferies, J. L., & Lorts, A. (2014) · Pediatric Cardiology · doi:10.1007/s00246-014-1042-z · Cited by 21 · see citing works

The herbal extract KCHO-1 exerts a neuroprotective effect by ameliorating oxidative stress via heme oxygenase-1 upregulation

Lee, D., Ko, W., Song, B.-K., Son, I., Kim, D.-W., Kang, D. G., Lee, H.-S., Oh, H., Jang, J., Kim, Y.-E., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5129 · Cited by 21 · see citing works

A novel pyrazole-containing selenium compound modulates the oxidative and nitrergic pathways to reverse the depression-pain syndrome in mice

Birmann, P. T., Casaril, A. M., Hartwig, D., Jacob, R. G., Seixas, F. K., Collares, T. V., & Savegnago, L. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146880 · Cited by 21 · see citing works

Ethical issues in susceptibility genetic testing for late‐onset neurodegenerative diseases

de Lara, A. M., Soto‐Gómez, L., Núñez‐Acosta, E., Zavala, G. S., & Rentería, M. E. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32699 · Cited by 21 · see citing works

Optimizing Parkinson’s Disease Prediction: A Comparative Analysis of Data Aggregation Methods Using Multiple Voice Recordings via an Automated Artificial Intelligence Pipeline

Yang, Z., Zhou, H., Srivastav, S., Shaffer, J. G., Abraham, K. T., Naandam, S. M., & Kakraba, S. (2025) · Data · doi:10.3390/data10010004 · Cited by 20 · see citing works

Managing Ethical Dilemmas in End-Stage Neurodegenerative Diseases

Low, J., & Ho, E. P. Y. (2017) · Geriatrics · doi:10.3390/geriatrics2010008 · Cited by 20 · see citing works

Prospective Evaluation of Predictive DNA Testing for Huntington's Disease in a Large German Center

Ibisler, A., Ocklenburg, S., Stemmler, S., Arning, L., Epplen, J. T., Carsten Saft, C., & Hoffjan, S. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0085-8 · Cited by 20 · see citing works

Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia

Surampalli, A., Khare, M., Kubrussi, G., Wencel, M., Tanaja, J., Donkervoort, S. C., Osann, K., Simon, M. T., Wallace, D. C., Smith, C. D., et al. (2015) · Journal of Genetic Counseling · doi:10.1007/s10897-015-9819-7 · Cited by 20 · see citing works

Phosphatidylserine: An overview on functionality, processing techniques, patents, and prospects

Chen, J., Li, J., Xu, H., Li, J., Yuan, Y., Xu, X., & Bi, Y. (2023) · Grain & Oil Science and Technology · doi:10.1016/j.gaost.2023.11.001 · Cited by 19 · see citing works

Reprogramming of HUVECs into Induced Pluripotent Stem Cells (HiPSCs), Generation and Characterization of HiPSC-Derived Neurons and Astrocytes

Haile, Y. G., Nakhaei‐Nejad, M., Boakye, P. A., Baker, G. B., Smith, P. A., Murray, A. G., Giuliani, F., & Jahroudi, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119617 · Cited by 19 · see citing works

Reconceptualizing Harms and Benefits in the Genomic Age

Prince, A. E. R., & Berkman, B. E. (2018) · Personalized Medicine · doi:10.2217/pme-2018-0022 · Cited by 19 · see citing works

Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know

Schwartz, M., Brandel, J., Babonneau, M.-L., Boucher, C., Schaerer, É., Haı̈k, S., Laplanche, J., Gargiulo, M., & Dürr, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00895 · Cited by 18 · see citing works

omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases

Alvarado, C. X., Makarious, M. B., Weller, C. A., Vitale, D., Koretsky, M. J., Bandrés‐Ciga, S., Iwaki, H., Levine, K. S., Singleton, A., Faghri, F., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.12.006 · Cited by 19 · see citing works

Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in Caenorhabditis elegans

Tortajada-Pérez, J., Carranza, A. D. V., Río, C. T.-D., Collado-Pérez, M., Millán, J. M., García‐García, G., & Vázquez‐Manrique, R. P. (2025) · Antioxidants · doi:10.3390/antiox14010078 · Cited by 19 · see citing works

HD-PRO-TRIAD™ Validation: A Patient-reported Instrument for the Symptom Triad of Huntington’s Disease

Carlozzi, N. E., Victorson, D. E., Sung, V., Beaumont, J. L., Cheng, W. Y., Gorin, B., Duh, M. S., Samuelson, D., Tulsky, D. S., Gutiérrez, S., et al. (2014) · Europe PMC (PubMed Central) · doi:10.7916/d8pn93nz · Cited by 18 · see citing works

People's interest in brain health testing: Findings from an international, online cross-sectional survey

Carver, R. B., Fredheim, N. A. G., Mowinckel, A. M., Ebmeier, K. P., Friedman, B. B., Rosness, T. A., Drevon, C. A., Suri, S., Baaré, W. F. C., Zsoldos, E., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.998302 · Cited by 17 · see citing works

Identification of Prodromal Parkinson Disease

Rees, R. N., Noyce, A. J., & Schrag, A. E. (2024) · Neurology · doi:10.1212/wnl.0000000000209394 · Cited by 17 · see citing works

Parkinsons Detection from Gait Time Series Classification Using Modified Metaheuristic Optimized Long Short Term Memory

Marković, F. N., Jovanović, L., Spalević, P., Kaljević, J., Zivkovic, M. Z., Šimić, V., Shaker, H., & Bačanin, N. (2025) · Neural Processing Letters · doi:10.1007/s11063-025-11735-z · Cited by 17 · see citing works

Understanding domains that influence perceived stigma in individuals with Huntington disease.

Boileau, N. R., Paulsen, J. S., Ready, R. E., Hahn, E. A., Lai, J., & Carlozzi, N. E. (2020) · Rehabilitation Psychology · doi:10.1037/rep0000311 · Cited by 15 · see citing works

The lived experience of reconstructing identity in response to genetic risk of frontotemporal degeneration and amyotrophic lateral sclerosis

Dratch, L., Owczarzak, J., Mu, W., Cousins, K. A. Q., Massimo, L. M., Grossman, M., & Erby, L. H. (2023) · Journal of Genetic Counseling · doi:10.1002/jgc4.1749 · Cited by 15 · see citing works

What ARE Parkinson disease? Non-motor features transform conception of the shaking palsy

Jain, S., & Goldstein, D. S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.013 · Cited by 15 · see citing works

Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians

Sherman, C. W., Iyer, R. G., Abler, V., Antonelli, A., & Carlozzi, N. E. (2019) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2018.1564675 · Cited by 14 · see citing works

Perspectives of People At-Risk on Parkinson’s Prevention Research

Keavney, J. L., Mathur, S., Schroeder, K., Merrell, R., Castillo‐Torres, S. A., Gao, V., Crotty, G. F., Schwarzschild, M. A., & Poma, J. M. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230436 · Cited by 14 · see citing works

A New Approach to Assessing Affect and the Emotional Implications of Personal Genomic Testing for Common Disease Risk

O’Neill, S. C., Tercyak, K. P., Baytop, C., Alford, S. H., & McBride, C. M. (2015) · Public Health Genomics · doi:10.1159/000370101 · Cited by 14 · see citing works

“I have to start learning how to live with becoming sick”: A scoping review of the lived experiences of people with Huntington's disease

Mahmood, S., Law, S., & Bombard, Y. (2021) · Clinical Genetics · doi:10.1111/cge.14024 · Cited by 14 · see citing works

Identifying Motor, Emotional–Behavioral, and Cognitive Deficits that Comprise the Triad of HD Symptoms from Patient, Caregiver, and Provider Perspectives

Victorson, D. E., Carlozzi, N. E., Frank, S., Beaumont, J. L., Cheng, W. Y., Gorin, B., Duh, M. S., Samuelson, D., Tulsky, D. S., Gutiérrez, S., et al. (2014) · Europe PMC (PubMed Central) · doi:10.7916/d8jw8bws · Cited by 14 · see citing works

Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing

McCusker, E. A., & Loy, C. T. (2017) · PubMed Central · doi:10.7916/d8pk0tdd · Cited by 13 · see citing works

The Effect of Predictive Testing in Adult‐Onset Neurodegenerative Diseases on Social and Personal Life

Cohn‐Hokke, P. E., Swieten, J. C. V., Pijnenburg, Y. A. L., Tibben, A., Meijers-Heijboer, H. E. J., & Kievit, A. J. A. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0195-3 · Cited by 13 · see citing works

Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health

Ahlgrim, N. S., Garza, K. M., Hoffman, C. A., & Rommelfanger, K. S. (2019) · eNeuro · doi:10.1523/eneuro.0439-18.2019 · Cited by 14 · see citing works

A novel α-ketoamide reactivity-based two-photon fluorogenic probe for visualizing peroxynitrite in Parkinson’s disease models

Shao, T., Xu, X., Wang, L., Shen, Y., Zhao, J., Li, H., Zhang, D., Du, W., Bai, H., Peng, B., et al. (2022) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545822500390 · Cited by 12 · see citing works

Direct-to-consumer tests advertised online in Australia and their implications for medical overuse: systematic online review and a typology of clinical utility

Shih, P., Ding, P., Carter, S. M., Stanaway, F., Horvath, A. R., Langguth, D., Saad, M., John, A. S., & Bell, K. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074205 · Cited by 12 · see citing works

BrainNeXt: novel lightweight CNN model for the automated detection of brain disorders using MRI images

Poyraz, M., Poyraz, A. K., Doğan, Y., Gunes, S., Mir, H., Paul, J. K., Barua, P. D., Bayğın, M., Doğan, Ş., Tuncer, T., et al. (2025) · Cognitive Neurodynamics · doi:10.1007/s11571-025-10235-z · Cited by 12 · see citing works

The Clinical Spectrum of Young Onset Dementia Points to Its Stochastic Origins

Panegyres, P. K. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210309 · Cited by 12 · see citing works

Implementation of a diagnostic decision aid for people with memory complaints and their general practitioners: a protocol of a before and after pilot trial

Linden, I., Wolfs, C. A. G., Perry, M., Metsemakers, J. F. M., van der Weijden, T., de Vugt, M. E., Verhey, F. R. J., Handels, R. L. H., Rikkert, M. G. M. O., Dirksen, C. D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049322 · Cited by 11 · see citing works

Unlocking Access to Broad Molecular Profiling: Benefits, Barriers, and Policy Solutions

Thomas, D. M., Hackett, J. M., & Pleština, S. (2021) · Public Health Genomics · doi:10.1159/000520000 · Cited by 11 · see citing works

Health survey of adults with hereditary spastic paraparesis compared to population study controls

Fjermestad, K. W., Kanavin, O. J., Næss, E. E., Hoxmark, L. B., & Hummelvoll, G. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0469-0 · Cited by 11 · see citing works

Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease

Goswami, S., Hartz, S. M., Oliver, A., Jackson, S., Ogungbenle, T., Evans, A., Linnenbringer, E. L., Moulder, K. L., Morris, J. C., & Mozersky, J. T. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.2919 · Cited by 10 · see citing works

Impacts of apolipoprotein E disclosure on healthy Asian older adults: a cohort study

Sng, W. T., Yeo, S. N., Lin, X. B., & Lee, T.-S. W. (2019) · International Psychogeriatrics · doi:10.1017/s1041610218002089 · Cited by 10 · see citing works

Regulation of Superoxide by BAP31 through Its Effect on p22phox and Keap1/Nrf2/HO‐1 Signaling Pathway in Microglia

Liu, X., Yuan, Q., Li, G., Jia, C., Liu, J., Yang, Y., Wang, X., Hou, Y., & Wang, B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1457089 · Cited by 10 · see citing works

Ethical Issues Raised by Epigenetic Testing for Alcohol, Tobacco, and Cannabis

Erwin, C. J. (2015) · Behavioral Sciences & the Law · doi:10.1002/bsl.2204 · Cited by 10 · see citing works

Completed Suicide in An Autopsy-Confirmed Case of Early Onset Alzheimer’s Disease

Hartzell, J. W., Geary, R., Gyure, K. A., Chivukula, V. R., & Haut, M. W. (2018) · Neurodegenerative Disease Management · doi:10.2217/nmt-2017-0045 · Cited by 9 · see citing works

Take the First-Person Perspective to Become Dementia-Friendly: The Use of 360° Video for Experiencing Everyday-Life Challenges With Cognitive Decline

Morganti, F., Palena, N., Savoldelli, P., & Greco, A. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01117 · Cited by 9 · see citing works

Risk disclosure in prodromal Parkinson's disease – A survey of neurologists

Kayiş, G., Yılmaz, R., Arda, B., & Akbostancı, M. C. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.105240 · Cited by 9 · see citing works

Predictors of Workplace Disability in a Premanifest Huntington’s Disease Cohort

Goh, A. M. Y., You, E., Perin, S., Clay, F. J., Loi, S., Ellis, K., Chong, T., Ames, D., & Lautenschlager, N. (2018) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.17040086 · Cited by 8 · see citing works

A Systematic Review on Confidentiality, Disclosure, and Stigma in the United States: Lessons for HIV Care in Pregnancy From Reproductive Genetics

Wilkinson, B. E., & Arora, K. S. (2015) · The New Bioethics · doi:10.1179/2050287715z.00000000067 · Cited by 8 · see citing works

Prognoza: Parkinson’s Disease Prediction Using Classification Algorithms

Shivakoti, M., Medaramatla, S. C., Godavarthi, D., & Shivakoti, N. (2023) · EAI Endorsed Transactions on Pervasive Health and Technology · doi:10.4108/eetpht.9.3933 · Cited by 8 · see citing works

Individuals' experiences in genetic counseling and predictive testing for familial amyotrophic lateral sclerosis

Steigerwald, C. G., Bertolini, C., McElhiney, M. C., Bergner, A. L., Harms, M. B., & Harrington, E. A. (2024) · Journal of Genetic Counseling · doi:10.1002/jgc4.1890 · Cited by 8 · see citing works

The Effect of Predictive Testing in Adult‐Onset Neurodegenerative Diseases on Social and Personal Life

Cohn‐Hokke, P. E., Swieten, J. C. V., Pijnenburg, Y. A. L., Tibben, A., Meijers-Heijboer, H. E. J., & Kievit, A. J. A. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0195-3 · Cited by 13 · see citing works

Predictive testing for neurodegenerative diseases in the age of next‐generation sequencing

Goldman, J. S., Xie, S., Green, D., Naini, A., MANSUKHANI, M. M., & Marder, K. S. (2020) · Journal of Genetic Counseling · doi:10.1002/jgc4.1342 · Cited by 7 · see citing works

Implications of predictive testing in neurodegenerative disorders

(2006) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2006.01788 · Cited by 1 · see citing works

ETHICAL AND GENETIC ASPECTS REGARDING PRESYMPTOMATIC TESTING FOR NEURODEGENERATIVE DISEASES.

Cozaru, G. C., Aşchie, M., Mitroi, A. F., Poinăreanu, I., & Gorduza, E. V. (2016) · The Medical-Surgical Journal · Cited by 5 · see citing works

How do we manage genetic testing for neurodegenerative diseases?

Yoshida, K. (2008) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.48.884